Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Neuro-Oncology Advances
|
April 30, 2026
A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma
Elizabeth C Cordell, Maikel Mansour, Austin R Pantel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET Images of Ovarian Cancer
Anthony J Young, Austin R Pantel, Varsha Viswanath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
Michael J Morris, Steven P Rowe, Michael A Gorin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET in Breast Cancer
Anthony J Young, Austin R Pantel, Mahsa Kiani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PET
Ali Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma
Elizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
Austin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Neuro-Oncology Advances
|
April 30, 2026
A phase 2 study of niraparib concomitant with tumor treating fields in patients with recurrent grade 4 glioma
Elizabeth C Cordell, Maikel Mansour, Austin R Pantel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 2021
Kinetic and Static Analysis of Poly-(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET Images of Ovarian Cancer
Anthony J Young, Austin R Pantel, Varsha Viswanath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 24, 2021
Diagnostic Performance of <sup>18</sup>F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study
Michael J Morris, Steven P Rowe, Michael A Gorin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 30, 2024
Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted <sup>18</sup>F-Fluorthanatrace PET in Breast Cancer
Anthony J Young, Austin R Pantel, Mahsa Kiani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PET
Ali Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma
Elizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 28, 2022
[18F]FluorThanatrace ([18F]FTT) PET Imaging of PARP-Inhibitor Drug-Target Engagement as a Biomarker of Response in Ovarian Cancer, a Pilot Study
Austin R Pantel, Sarah B Gitto, Mehran Makvandi, et al.
Page
of 9